Sign In
30 Jan 2012 07:00
Immunodiagnostic Systems Holdings plc
("IDS" or the "Company")
Director/PDMR Shareholding
Immunodiagnostic Systems Holdings plc (AIM: IDH), a leading producer of diagnostic testing kits and automated systems for the clinical and research markets, announces that it was informed on 27 January, 2012 of a number of share purchases by Directors.
The transactions are summarised below. The percentage holding calculations are based on the Company's issued share capital of 28,403,469 ordinary shares of 2p each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury.
Director | Number of Ordinary Shares Purcased | Purchase price | Resulting holding | Resulting % |
Paul Hailes, Finance Director | 6,500 | 309.00p | 547,189 | 1.93% |
Roger Duggan, Deputy Chairman & Business Development Director |
6,300 |
308.57p |
1,532,587 |
5.40% |
For further information:
Immunodiagnostic Systems Holdings plc | Tel: 0191 519 0660 |
Ian Cookson, Chief Executive Officer Paul Hailes, Finance Director | |
Brewin Dolphin Limited | Tel: 020 3201 3710 |
Aubrey Powell Luke Boyce | |
Walbrook PR Ltd | Tel: 020 7933 8780 |
Paul McManus | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com |
Fiona Henson | Mob: 07886 335 992 or fiona.henson@walbrookpr.com |
IDH.L (IDH)
Follow the stocks
